Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • British Skin Foundation

    - PMLiVE

    Global Healthy Living Foundation and Medscape Education Join Forces to Bridge the Gap Between Patients and Providers with Immunology Education

    UPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) today announced a new partnership with Medscape Education to advance patient-centered innovation within the Immunology Learning Nexus (Nexus), Medscape’s flagship multi-year...

    Medscape Education

    - PMLiVE

    Almirall and Absci expand AI dermatological drug discovery partnership

    The alliance has already led to the delivery of functional antibody leads against a difficult-to-drug target

    - PMLiVE

    Apogee Therapeutics’ atopic dermatitis candidate shows promise in phase 2 study

    The inflammatory skin condition affects over 26 million people in the US

    - PMLiVE

    Honoring the Legacy of Dr. Robert Sidbury, MD, MPH

    We are deeply saddened by the recent passing of Dr. Robert Sidbury. Dr. Sidbury was a visionary in pediatric dermatology whose dedication to advancing patient care inspired clinicians, researchers, and...

    Medscape Education

    - PMLiVE

    LEO Pharma gains access to Boehringer’s skin disease drug for €90m upfront

    Spevigo is already approved in over 40 countries to treat generalised pustular psoriasis

    - PMLiVE

    Dermaliq and DEBRA partner to advance epidermolysis bullosa drug delivery

    Approximately 500,000 people worldwide are affected by the rare genetic skin disorders

    - PMLiVE

    LEO Pharma and the Parker Institute join forces to advance dermatology research

    The alliance will aim to discover molecules that could be incorporated into wider pharmaceutical research

    - PMLiVE

    NHS programme to give melanoma patients fast-track access to skin cancer vaccine

    The phase 2 study will evaluate Scancell's iSCIB1+ in patients with advanced unresectable melanoma

    - PMLiVE

    LEO and Reig Jofre partner to improve access to psoriasis therapy in Europe

    Approximately 125 million people worldwide are affected by some form of the inflammatory condition

    - PMLiVE

    LEO and DEBRA Research partner to advance epidermolysis bullosa treatments

    There is currently no cure for the group of rare inherited skin disorders

    - PMLiVE

    LEO Pharma’s Anzupgo cream granted MHRA approval to treat chronic hand eczema

    Anzupgo is the first topical pan-JAK inhibitor approved specifically for adults with moderate-to-severe cases

    - PMLiVE

    Galderma announces positive late-stage results for nemolizumab in prurigo nodularis

    The chronic skin condition is estimated to affect up to 181,000 people in the US

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links